AVYCAZ (Allergan, Inc.)


Welcome to the PulseAid listing for the AVYCAZ drug offered from Allergan, Inc.. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: ceftazidime, avibactam
SUBSTANCE NAME: CEFTAZIDIME; AVIBACTAM SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-12-26
END MARKETING DATE: 0000-00-00


AVYCAZ HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAVYCAZ from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2; .5(g/1; g/1)
START MARKETING DATE: 2014-12-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0456-2700_992ae248-b6ba-48da-a504-4cb9bdaa488c
PRODUCT NDC: 0456-2700
APPLICATION NUMBER: NDA206494

Other CEFTAZIDIME; AVIBACTAM SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.AVYCAZ